Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05009420 · ClinicalTrials.gov registry record · NA
Validation of Avocatin b as a Biomarker of Food Intake
A NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05009420 is a NA study that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 10 participants.
The verdict
NCT05009420, a NA study, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The primary objectives are to * Identify avocatin b (C17 lipid) in plasma of individuals that consumed 1 avocado. * Confirm no avocation b present in the plasma of individuals that avoided avocado intake for 7 days. * Determine the effect of an overnight fast on avocation b detection.
Interventions
- OTHER Avocado
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-07-19 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05009420
The ClinicalTrials.gov registry entry for NCT05009420 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Avocado is the first listed.
NCT05009420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05009420 about?
NCT05009420 is a clinical study titled "Validation of Avocatin b as a Biomarker of Food Intake". The primary objectives are to * Identify avocatin b (C17 lipid) in plasma of individuals that consumed 1 avocado. * Confirm no avocation b present in the plasma of individuals that avoided avocado intake for 7 days. * Determine the effect of an overnight fast on avocation b detection.
What is the current status of trial NCT05009420?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-07-19. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT05009420?
The interventions under investigation include: Avocado (OTHER).
Who is sponsoring clinical trial NCT05009420?
This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.